Description
Phonyx Peptides DSIP 5 mg is a clearly labeled research peptide vial containing a stated total amount of 5 mg of DSIP. The product is presented in a professional dark glass vial with a metallic cap and a silver, white and gold Phonyx Peptides label.
The front label identifies the compound as DSIP, displays the total content as 5 MG and includes the designation Research Use Only. The packaging also shows a lot number and expiry date, supporting clear product identification, laboratory inventory control and research documentation.
For researchers and laboratories seeking a defined DSIP research material, this presentation offers a straightforward single-compound format with visible labeling, traceability information and a professional appearance suitable for organized peptide storage.
What Is DSIP?
DSIP is a peptide commonly discussed in laboratory research involving sleep-related peptide pathways, biological signaling and peptide characterization. This product is presented as a single-compound DSIP research vial, allowing it to be catalogued separately from combination products or other peptide materials.
The supplied vial is labeled with a total content of 5 mg. No unsupported purity percentage, sterility claim or biological-performance claim should be inferred from the image or product label alone. Researchers should consult the accompanying documentation and certificate of analysis, where available, before beginning laboratory work.
Clearly Labeled 5 mg Format
The product is marked 5 MG on the front label for quick identification. The large DSIP product name and clear total amount make the vial easy to distinguish during receiving, inventory management and laboratory sample organization.
The label also includes a lot number and expiry date. These details should be recorded exactly as printed on the physical vial and retained with the order documentation. Lot and expiry information can help researchers maintain a traceable record when several peptide materials are stored in the same facility.
The visible label confirms the product name and stated amount, but visual inspection alone cannot verify chemical identity, purity, sterility or suitability for a specific experiment.
Phonyx Peptides Packaging
Phonyx Peptides DSIP is supplied in a dark glass vial with a metallic cap and a professionally designed branded label. The silver and gold presentation gives the product strong visual identity for online catalogues, laboratory stock systems and product photography.
The label places the Phonyx Peptides brand at the top, DSIP in a prominent central position and the stated 5 mg content below it. A DNA-style graphic and molecular design reinforce the product’s research-oriented presentation without replacing formal analytical documentation.
Keep the vial in its original packaging. Removing or replacing the label can separate the material from its compound name, total amount, lot number and expiry date.
Key Product Features
Single-compound format: The vial is labeled specifically as DSIP, making it easy to distinguish from peptide blends.
5 mg stated content: The total amount is displayed clearly on the front of the label.
Professional research packaging: The product is supplied in a dark glass vial with a metallic cap and branded Phonyx Peptides label.
Lot traceability: The label includes a lot number for inventory and documentation purposes.
Expiry information: The label displays an expiry date for stock-control records.
Research designation: The packaging is clearly marked Research Use Only.
Product Specifications
Brand: Phonyx Peptides
Product: DSIP
Total labeled content: 5 mg
Product form: Labeled research peptide vial
Packaging: Dark glass vial with metallic cap
Lot information: Printed on the product label
Expiry information: Printed on the product label
Label designation: Research Use Only
Research Applications
DSIP may be catalogued for laboratory research involving peptide identity, analytical characterization, stability assessment, formulation studies and controlled assay development. A clearly labeled single-compound vial can be useful when researchers need to maintain separate records for individual peptide materials.
Any research application should be selected by qualified personnel according to institutional procedures, applicable regulations, validated methods and appropriate laboratory controls. The product name should not be used to imply a proven clinical effect or a guaranteed outcome in humans or animals.
The stated 5 mg amount is useful for product comparison and inventory management. It does not replace independent analytical confirmation of the sample’s identity, purity or other quality attributes.
What Research Shows About DSIP
DSIP, or delta sleep-inducing peptide, has been investigated primarily in relation to sleep regulation, sleep architecture and neurobiological responses associated with rest. The name reflects the original research interest in delta-wave and sleep-related activity, but the available evidence is not strong enough to present DSIP as a proven sleep treatment or guaranteed sleep aid.
A double-blind, placebo-controlled study indexed in PubMed examined DSIP in 16 people with chronic insomnia. The researchers reported higher objective sleep efficiency and shorter sleep latency compared with placebo, and one measure of subjective tiredness decreased within the DSIP group . However, the authors described the statistically significant effects as weak, noted that some findings could reflect an incidental change in the placebo group, and found no improvement in several other measures, including subjective sleep quality. Their conclusion was that short-term DSIP treatment was unlikely to provide a major therapeutic benefit .
These findings give DSIP a legitimate research profile in sleep-related peptide studies, but they also define the appropriate marketing language. A responsible product description may refer to sleep-regulation research, polysomnography, sleep latency and sleep efficiency; it should not promise deeper sleep, treatment of insomnia, next-day recovery or a guaranteed change in sleep quality.
The molecular mechanism of DSIP remains incompletely resolved. Research continues to examine how the peptide may interact with neurochemical systems involved in sleep and stress, but the existing evidence does not justify presenting a single definitive receptor mechanism or an established clinical pathway. The present vial should therefore be described as a research material for analytical and experimental work rather than as an approved medicine.
The cited human study evaluated a specific experimental protocol and does not establish that every DSIP product, formulation, route or batch has the same effect. The labeled 5 mg amount on this vial confirms the stated product quantity only; it does not confirm purity, biological activity or clinical effectiveness.
Quality and Documentation
For responsible research purchasing, retain the original label, lot number, expiry date, order information and any documentation supplied with the vial. These records support traceability from delivery through storage and laboratory use.
Where a certificate of analysis is available, compare its product name, lot number, test method, reported purity and test date with the physical vial. Documentation should correspond to the exact lot being evaluated rather than to a different batch or similarly named peptide.
The appearance of a vial cannot confirm DSIP identity or purity. Unusual particles, damaged packaging, leakage, an unreadable label or a mismatch between the documentation and the physical product should be recorded and referred to the supplier before the material is used.
Storage and Handling
Store the vial according to the manufacturer’s instructions and the applicable laboratory standard operating procedure. Protect it from unsuitable temperatures, direct light, moisture, contamination and unnecessary handling.
Do not remove or replace the original label. The lot and expiry details are important for traceability, especially when different peptides are stored in the same research environment.
The product should be handled only by trained personnel using appropriate laboratory controls. Researchers should establish their own validated storage, preparation, handling and disposal procedures rather than relying on general online product descriptions.
Product Identification and Traceability
The combination of the DSIP name, 5 mg marking, Phonyx Peptides branding, lot number and expiry date provides a practical identification framework for the labeled vial. These details can be entered into a laboratory inventory system together with the date received, storage location and associated documentation.
Accurate cataloguing helps prevent mix-ups between single-compound peptides and combination products. It also makes it easier to locate the correct vial when reviewing a research record or checking the status of an expired lot.
For online presentation, showing the product name and stated amount clearly supports customer understanding while keeping the listing aligned with the information visible on the physical label.
Why Choose Phonyx Peptides DSIP 5 mg?
This product is designed for customers looking for a clearly identified DSIP 5 mg research peptide vial from Phonyx Peptides. Its strongest commercial features are the prominent compound name, visible 5 mg marking, professional dark-glass packaging, lot identification and expiry information.
The single-compound format makes DSIP easy to distinguish from Selank + Semax blends and other multi-peptide products. Clean labeling and traceability details help laboratories compare research materials and maintain organized peptide inventories.
Research Use Only. Not intended for human use, veterinary use, diagnosis, treatment or consumption.
Reference
[1] Phonyx Peptides official website
[2] Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients